Inventor profile of:

Steven Witowski

City:

Melrose, Massachusetts

Country:

United States

Published Applications:

17

Last publication date:

2023-10-05

Top Assignees for applications by Steven Witowski

The entities that hold a legal rights for patent applications filed by inventor Witowski Steven:

Recent patent applications by Witowski Steven

Steven Witowski from Melrose, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-10-05
US20230310329A1
Human necessities

Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

#2 | 2022-04-28
US20220125734A1
Human necessities

Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

#3 | 2021-09-23
US20210290554A1
Human necessities

Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

#4 | 2019-01-31
US20190029967A1
Human necessities

Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

#5 | 2015-05-14
US20150132375A1
Human necessities

Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

#6 | 2015-01-29
US20150031632A1
Human necessities

Orally Disintegrating Compositions of Linaclotide

#7 | 2014-11-27
US20140349948A1
Human necessities

Treatment of Chronic Constipation

#8 | 2014-09-25
US20140287034A1
Human necessities

Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

#9 | 2013-10-17
US20130273169A1
Human necessities

Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

#10 | 2013-07-25
US20130190239A1
Human necessities

Formulations Comprising Linaclotide

#11 | 2013-03-07
US20130059797A1
Human necessities

Linaclotide for the Treatment of Chronic Constipation

#12 | 2013-01-10
US20130012454A1
Human necessities

Orally Disintegrating Compositions of Linaclotide

#13 | 2012-08-23
US20120213846A1
Human necessities

Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

#14 | 2012-02-16
US20120039949A1
Human necessities

Stable Solid Formulations of GC-C Receptor Agonist Polypeptides Suitable for Oral Administration

#15 | 2012-01-12
US20120009225A1
Human necessities

Stable Solid Formulation of Therapeutic Polypeptides Suitable for Oral Administration

#16 | 2011-03-10
US20110059903A1
Human necessities

Formulations comprising linaclotide

#17 | 2010-02-25
US20100048489A1
Human necessities

Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration

InventorID:

29718 ⎘